However, recent large-scale meta-analyses support the hypothesis of immune dysregulation in AD and mild cognitive impairment, reporting elevated peripheral levels of CRP, IL6 and IL1β in AD compared to controls [5, 6]. The gene discussed is IL1B; the disease is Alzheimer disease.